Skip to main navigation Skip to search Skip to main content

Safety and immunogenicity of a novel Rift Valley fever candidate vaccine, RVax-1

Project: Research project

Project Details

StatusActive
Effective start/end date3/10/20 → 2/28/27

Funding

  • National Institute of Allergy and Infectious Diseases ( Award #5R01AI15091705): $1,931,055.00